{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:59:32Z","timestamp":1781657972922,"version":"3.54.5"},"reference-count":90,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T00:00:00Z","timestamp":1668038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Rheumatoid arthritis (RA) has been associated with changes in lipid, arginine and NO metabolism with increased cardiovascular (CV) risk. The aim of this study is to evaluate the effect of tofacitinib, a Janus kinase (JAK) inhibitor, on arginine and methionine metabolism in correlation with inflammation, functional and pathological vascular changes during one-year treatment of patients with RA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>Thirty RA patients with active disease were treated with either 5 mg bid or 10 mg bid tofacitinib for 12 months. We determined DAS28, CRP, IgM rheumatoid factor (RF) and anti-cyclic citrullinated peptide (CCP) levels. We assessed brachial artery flow-mediated vasodilation (FMD), carotid intima-media thickness (IMT) and pulse-wave velocity (PWV) by ultrasound at baseline and after 6 and 12 months. We also determined plasma L-arginine, L-citrulline, L-ornithine, inducible nitric oxide synthase (iNOS), asymmetric (ADMA) and symmetric dimethylarginine (SDMA), L-N-monomethyl-arginine (L-NMMA), cysteine, homocysteine, and methionine levels at these time points.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Twenty-six patients (13 on each arm) completed the study. CRP, ESR and DAS28 decreased significantly during one-year treatment with tofacitinib. Arginine and ADMA showed a negative univariate correlation with CRP but not with FMD, PWV or IMT. Tofacitinib at 10 mg bid significantly increased L-arginine, L-ornithine, iNOS and methionine levels after 12 months. ADMA and SDMA levels did not change in our study. Methionine showed negative correlation with FMD at baseline and positive correlation with PWV after 12 months. No change was observed in FMD and PWV but a significant increase was measured in IMT at 6 and 12 months. Multivariate analysis indicated variable correlations of L-arginine, L-citrulline, ADMA, L-NMMA, homocysteine and methionine with DAS28, CRP, ESR and RF but not with anti-CCP after one-year treatment. With respect to vascular pathophysiology, only PWV and methionine correlated with each other.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>One-year tofacitinib treatment suppressed systemic inflammation and improved functional status in RA. FMD, PWV have not been affected by one-year tofacitinib treatment., while IMT increased further despite treatment. Increased arginine and methionine might contribute to the anti-inflammatory effects of tofacitinib. Increased arginine availability with no changing ADMA may protect FMD and PWV from deterioration. The increase of IMT in the anti-inflammatory environment cannot be explained by arginine or methionine metabolism in this study.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2022.1011734","type":"journal-article","created":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T06:14:33Z","timestamp":1668060873000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Effects of tofacitinib therapy on arginine and methionine metabolites in association with vascular pathophysiology in rheumatoid arthritis: A metabolomic approach"],"prefix":"10.3389","volume":"9","author":[{"given":"Bogl\u00e1rka","family":"So\u00f3s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attila","family":"Hamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Pusztai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Cz\u00f3kolyov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edit","family":"V\u00e9gh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szilvia","family":"Szamosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zs\u00f3fia","family":"Peth\u0151","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin","family":"Guly\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gy\u00f6rgy","family":"Kerekes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e1ndor","family":"Sz\u00e1nt\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Sz\u0171cs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Christians","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Klawitter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam\u00e1s","family":"Seres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Szekanecz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,10]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative.","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann Rheum Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.0105-2896.2009.00850.x","article-title":"Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis.","volume":"233","author":"Wegner","year":"2010","journal-title":"Immunol Rev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1002\/art.21220","article-title":"Synovial intracellular citrullinated proteins colocalizing with peptidyl arginine deiminase as pathophysiologically relevant antigenic determinants of rheumatoid arthritis-specific humoral autoimmunity.","volume":"52","author":"De Rycke","year":"2005","journal-title":"Arthritis Rheum."},{"key":"B4","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1136\/annrheumdis-2012-201484","article-title":"Genetic and environmental determinants for disease risk in subsets of rheumatoid arthritis defined by the anticitrullinated protein\/peptide antibody fine specificity profile.","volume":"72","author":"Lundberg","year":"2013","journal-title":"Ann Rheum Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/BOR.0000000000000277","article-title":"The role of anticitrullinated protein antibodies in the early stages of rheumatoid arthritis.","volume":"28","author":"Dekkers","year":"2016","journal-title":"Curr Opin Rheumatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s11926-001-0051-0","article-title":"Update on synovitis.","volume":"3","author":"Szekanecz","year":"2001","journal-title":"Curr Rheumatol Rep."},{"key":"B7","doi-asserted-by":"publisher","first-page":"377","DOI":"10.2165\/00002512-199812050-00004","article-title":"Cytokines in rheumatoid arthritis. Potential targets for pharmacological intervention.","volume":"12","author":"Szekanecz","year":"1998","journal-title":"Drugs Aging."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2019.102397","article-title":"Macrophage M1\/M2 polarization and rheumatoid arthritis: A systematic review.","volume":"18","author":"Tardito","year":"2019","journal-title":"Autoimmun Rev."},{"key":"B9","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1093\/eurheartj\/ehr304","article-title":"Nitric oxide synthases: regulation and function.","volume":"33","author":"Forstermann","year":"2012","journal-title":"Eur Heart J."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00093","article-title":"Arginine metabolism in myeloid cells shapes innate and adaptive immunity.","volume":"8","author":"Rodriguez","year":"2017","journal-title":"Front Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj3360001","article-title":"Arginine metabolism: nitric oxide and beyond.","author":"Wu","year":"1998","journal-title":"Biochem J."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00533","article-title":"Functions of arginase isoforms in macrophage inflammatory responses: impact on cardiovascular diseases and metabolic disorders.","volume":"5","author":"Yang","year":"2014","journal-title":"Front Immunol."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/biom10091280","article-title":"Amino acid metabolism in rheumatoid arthritis: Friend or Foe?","volume":"10","author":"Panfili","year":"2020","journal-title":"Biomolecules."},{"key":"B14","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.tips.2015.03.006","article-title":"Arginase: an old enzyme with new tricks.","volume":"36","author":"Caldwell","year":"2015","journal-title":"Trends Pharmacol Sci."},{"key":"B15","first-page":"2261","article-title":"Increased expression of arginase II in patients with different forms of arthritis. Implications of the regulation of nitric oxide.","volume":"29","author":"Corraliza","year":"2002","journal-title":"J Rheumatol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1111\/1756-185X.12864","article-title":"Changes in the pattern of cytokine production from peripheral blood mononuclear cells in patients with rheumatoid arthritis treated with infliximab and their relation to plasma arginase activity.","volume":"21","author":"Miyoshi","year":"2018","journal-title":"Int J Rheum Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","article-title":"EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update.","volume":"76","author":"Agca","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/nrrheum.2015.112","article-title":"Cardiovascular comorbidity in rheumatic diseases.","volume":"11","author":"Nurmohamed","year":"2015","journal-title":"Nat Rev Rheumatol."},{"key":"B19","first-page":"398","article-title":"Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity.","volume":"35","author":"Kerekes","year":"2008","journal-title":"J Rheumatol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.semarthrit.2008.02.001","article-title":"Endothelial dysfunction, carotid intima-media thickness, and accelerated atherosclerosis in rheumatoid arthritis.","volume":"38","author":"Gonzalez-Gay","year":"2008","journal-title":"Semin Arthritis Rheum."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2019-001032","article-title":"Pathogenesis of ischaemic and non-ischaemic heart diseases in rheumatoid arthritis.","volume":"6","author":"Blyszczuk","year":"2020","journal-title":"RMD Open."},{"key":"B22","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1136\/ard.2010.135871","article-title":"Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease.","volume":"70","author":"Myasoedova","year":"2011","journal-title":"Ann Rheum Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/nrrheum.2014.121","article-title":"Rheumatoid arthritis and metabolic syndrome.","volume":"10","author":"Kerekes","year":"2014","journal-title":"Nat Rev Rheumatol."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9093026","article-title":"ADMA: A key player in the relationship between vascular dysfunction and inflammation in atherosclerosis.","volume":"9","author":"Dowsett","year":"2020","journal-title":"J Clin Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/ncpneph0143","article-title":"Arginine, arginine analogs and nitric oxide production in chronic kidney disease.","volume":"2","author":"Baylis","year":"2006","journal-title":"Nat Clin Pract Nephrol."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-017-1232-1","article-title":"Endothelial injury in rheumatoid arthritis: a crosstalk between dimethylarginines and systemic inflammation.","volume":"19","author":"Dimitroulas","year":"2017","journal-title":"Arthritis Res Ther."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-018-1616-x","article-title":"Elevated levels of plasma symmetric dimethylarginine and increased arginase activity as potential indicators of cardiovascular comorbidity in rheumatoid arthritis.","volume":"20","author":"Chandrasekharan","year":"2018","journal-title":"Arthritis Res Ther."},{"key":"B28","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jbspin.2010.05.009","article-title":"Increased production of asymmetric dimethylarginine (ADMA) in ankylosing spondylitis: association with other clinical and laboratory parameters.","volume":"78","author":"Kemeny-Beke","year":"2011","journal-title":"Joint Bone Spine."},{"key":"B29","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1002\/art.22424","article-title":"Elevated plasma asymmetric dimethyl-L-arginine levels are linked to endothelial progenitor cell depletion and carotid atherosclerosis in rheumatoid arthritis.","volume":"56","author":"Surdacki","year":"2007","journal-title":"Arthritis Rheum."},{"key":"B30","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s10067-019-04713-z","article-title":"Asymmetric and symmetric dimethylarginine concentration as an indicator of cardiovascular diseases in rheumatoid arthritis patients: a systematic review and meta-analysis of case-control studies.","volume":"39","author":"Zafari","year":"2020","journal-title":"Clin Rheumatol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/nrrheum.2012.16","article-title":"Validated methods for assessment of subclinical atherosclerosis in rheumatology.","volume":"8","author":"Kerekes","year":"2012","journal-title":"Nat Rev Rheumatol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14728222.2017.1370454","article-title":"Targeting methionine cycle as a potential therapeutic strategy for immune disorders.","author":"Li","year":"2017","journal-title":"Expert Opin Ther Targets."},{"key":"B33","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1139\/cjpp-2018-0112","article-title":"Homocysteine and homocysteine-related compounds: an overview of the roles in the pathology of the cardiovascular and nervous systems.","volume":"96","author":"Djuric","year":"2018","journal-title":"Can J Physiol Pharmacol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1042\/cs1000161","article-title":"Elevation of asymmetrical dimethylarginine may mediate endothelial dysfunction during experimental hyperhomocyst(e)inaemia in humans.","volume":"100","author":"Boger","year":"2001","journal-title":"Clin Sci (Lond)."},{"key":"B35","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.metabol.2004.09.015","article-title":"Relationship between S-adenosylmethionine, S-adenosylhomocysteine, asymmetric dimethylarginine, and endothelial function in healthy human subjects during experimental hyper- and hypohomocysteinemia.","volume":"54","author":"Doshi","year":"2005","journal-title":"Metabolism."},{"key":"B36","doi-asserted-by":"publisher","first-page":"H1334","DOI":"10.1152\/ajpheart.2001.280.3.H1334","article-title":"Evidence against oxidative stress as mechanism of endothelial dysfunction in methionine loading model.","volume":"280","author":"Nightingale","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.nut.2012.12.026","article-title":"The effect of hyperhomocysteinemia on aortic distensibility in healthy individuals.","volume":"29","author":"Eleftheriadou","year":"2013","journal-title":"Nutrition."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1097\/HJH.0000000000000647","article-title":"Effects of 2-year vitamin B12 and folic acid supplementation in hyperhomocysteinemic elderly on arterial stiffness and cardiovascular outcomes within the B-PROOF trial.","volume":"33","author":"van Dijk","year":"2015","journal-title":"J Hypertens."},{"key":"B39","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nrrheum.2009.219","article-title":"Vascular effects of biologic agents in RA and spondyloarthropathies.","volume":"5","author":"Szekanecz","year":"2009","journal-title":"Nat Rev Rheumatol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrrheum.2011.168","article-title":"Cardiovascular safety of biologic therapies for the treatment of RA.","volume":"8","author":"Greenberg","year":"2011","journal-title":"Nat Rev Rheumatol."},{"key":"B41","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1136\/annrheumdis-2019-216655","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update.","volume":"79","author":"Smolen","year":"2020","journal-title":"Ann Rheum Dis."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1136\/annrheumdis-2018-214846","article-title":"Impact of Janus kinase inhibitors on risk of cardiovascular events in patients with rheumatoid arthritis: systematic review and meta-analysis of randomised controlled trials.","volume":"78","author":"Xie","year":"2019","journal-title":"Ann Rheum Dis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/art.38894","article-title":"Lipid profile changes in patients with chronic inflammatory arthritis treated with biologic agents and tofacitinib in randomized clinical trials: a systematic review and meta-analysis.","volume":"67","author":"Souto","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2021-001804","article-title":"Prospective, simultaneous assessment of joint and vascular inflammation by PET\/CT in tofacitinib-treated patients with rheumatoid arthritis: associations with vascular and bone status.","volume":"7","author":"Hamar","year":"2021","journal-title":"RMD Open."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1007\/s00296-017-3844-9","article-title":"Tofacitinib improves atherosclerosis despite up-regulating serum cholesterol in patients with active rheumatoid arthritis: a cohort study.","volume":"37","author":"Kume","year":"2017","journal-title":"Rheumatol Int."},{"key":"B46","article-title":"Development and validation of the DAS28 using CRP.","volume":"62","author":"Fransen","year":"2003","journal-title":"Ann Rheum Dis."},{"key":"B47","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00296-019-04497-0","article-title":"Effects of 1-year anti-TNF-alpha therapy on vascular function in rheumatoid arthritis and ankylosing spondylitis.","volume":"40","author":"Vegh","year":"2019","journal-title":"Rheumatol Int."},{"key":"B48","doi-asserted-by":"publisher","first-page":"F1198","DOI":"10.1152\/ajprenal.00327.2014","article-title":"Endothelial dysfunction and oxidative stress in polycystic kidney disease.","volume":"307","author":"Klawitter","year":"2014","journal-title":"Am J Physiol Renal Physiol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1152\/japplphysiol.00819.2018","article-title":"Elevated plasma homocysteine and cysteine are associated with endothelial dysfunction across menopausal stages in healthy women.","volume":"126","author":"Keller","year":"2019","journal-title":"J Appl Physiol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences.","volume":"39","author":"Faul","year":"2007","journal-title":"Behav Res Methods."},{"key":"B51","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/mnfr.201300033","article-title":"Arginine and nitric oxide synthase: regulatory mechanisms and cardiovascular aspects.","volume":"58","author":"Lorin","year":"2014","journal-title":"Mol Nutr Food Res."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1602S","DOI":"10.1093\/jn\/137.6.1602S","article-title":"Arginine metabolism: boundaries of our knowledge.","volume":"137","author":"Morris","year":"2007","journal-title":"J Nutr."},{"key":"B53","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/s41568-019-0187-8","article-title":"Methionine metabolism in health and cancer: a nexus of diet and precision medicine.","volume":"19","author":"Sanderson","year":"2019","journal-title":"Nat Rev Cancer."},{"key":"B54","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1210\/jc.2007-2223","article-title":"Interleukin-6 markedly decreases skeletal muscle protein turnover and increases nonmuscle amino acid utilization in healthy individuals.","volume":"93","author":"van Hall","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"key":"B55","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/exd.14059","article-title":"The Janus Kinase inhibitor tofacitinib impacts human dendritic cell differentiation and favours M1 macrophage development.","volume":"29","author":"Stalder","year":"2020","journal-title":"Exp Dermatol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1002\/JLB.5RU0519-145R","article-title":"JAK inhibition by methotrexate (and csDMARDs) may explain clinical efficacy as monotherapy and combination therapy.","volume":"106","author":"Gremese","year":"2019","journal-title":"J Leukoc Biol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1002\/art.34340","article-title":"Increased recycling of polyamines is associated with global DNA hypomethylation in rheumatoid arthritis synovial fibroblasts.","volume":"64","author":"Karouzakis","year":"2012","journal-title":"Arthritis Rheum."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01070","article-title":"Betaine in inflammation: Mechanistic aspects and applications.","volume":"9","author":"Zhao","year":"2018","journal-title":"Front Immunol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s10067-007-0803-y","article-title":"TNF-alpha blockade induces a reversible but transient effect on endothelial dysfunction in patients with long-standing severe rheumatoid arthritis.","volume":"27","author":"Bosello","year":"2008","journal-title":"Clin Rheumatol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.semarthrit.2011.08.003","article-title":"Subclinical atherosclerosis and endothelial dysfunction in patients with early rheumatoid arthritis as evidenced by measurement of carotid intima-media thickness and flow-mediated vasodilatation: an observational study.","volume":"41","author":"Chatterjee Adhikari","year":"2012","journal-title":"Semin Arthritis Rheum."},{"key":"B61","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.atherosclerosis.2011.09.015","article-title":"A pilot study of endothelial dysfunction and aortic stiffness after interleukin-6 receptor inhibition in rheumatoid arthritis.","volume":"219","author":"Protogerou","year":"2011","journal-title":"Atherosclerosis."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1161\/CIRCULATIONAHA.105.601641","article-title":"Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy.","volume":"114","author":"Maki-Petaja","year":"2006","journal-title":"Circulation."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1007\/s00296-009-1155-5","article-title":"Arterial stiffness in a muscular artery in women with longstanding rheumatoid arthritis compared with healthy controls and patients with traditional cardiovascular risk factors.","volume":"30","author":"Pieringer","year":"2010","journal-title":"Rheumatol Int."},{"key":"B64","first-page":"832","article-title":"Impaired brachial artery flow-mediated dilation and increased carotid intima-media thickness in rheumatoid arthritis patients.","volume":"125","author":"Fan","year":"2012","journal-title":"Chin Med J (Engl)."},{"key":"B65","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1093\/rheumatology\/keg083","article-title":"Rheumatoid arthritis and macrovascular disease.","volume":"42","author":"Alkaabi","year":"2003","journal-title":"Rheumatology (Oxford)."},{"key":"B66","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s10067-006-0338-7","article-title":"Common carotid intima-media thickness and von Willebrand factor serum levels in rheumatoid arthritis female patients without cardiovascular risk factors.","volume":"26","author":"Daza","year":"2007","journal-title":"Clin Rheumatol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1056\/NEJMoa2109927","article-title":"Cardiovascular and cancer risk with tofacitinib in rheumatoid arthritis.","volume":"386","author":"Ytterberg","year":"2022","journal-title":"N Engl J Med."},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2020-001395","article-title":"Long-term safety of tofacitinib up to 9.5 years: a comprehensive integrated analysis of the rheumatoid arthritis clinical development programme.","volume":"6","author":"Cohen","year":"2020","journal-title":"RMD Open."},{"key":"B69","first-page":"388","article-title":"Lack of association between asymmetric dimethylarginine and in vivo microvascular and macrovascular endothelial function in patients with rheumatoid arthritis.","volume":"30","author":"Sandoo","year":"2012","journal-title":"Clin Exp Rheumatol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1080\/00365513.2016.1177852","article-title":"In vivo microvascular and macrovascular endothelial function is not associated with circulating dimethylarginines in patients with rheumatoid arthritis: a prospective analysis of the DRACCO cohort.","volume":"76","author":"Dimitroulas","year":"2016","journal-title":"Scand J Clin Lab Invest."},{"key":"B71","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1016\/j.jacc.2009.02.036","article-title":"Diminished global arginine bioavailability and increased arginine catabolism as metabolic profile of increased cardiovascular risk.","volume":"53","author":"Tang","year":"2009","journal-title":"J Am Coll Cardiol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.autrev.2016.03.014","article-title":"Autoimmune atherosclerosis in 3D: How it develops, how to diagnose and what to do.","volume":"15","author":"Szekanecz","year":"2016","journal-title":"Autoimmun Rev."},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1126\/stke.2712005re2","article-title":"Protein interfaces in signaling regulated by arginine methylation.","volume":"2005","author":"Boisvert","year":"2005","journal-title":"Sci STKE."},{"key":"B74","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.metabol.2006.10.023","article-title":"Dimethylarginines at the crossroad of insulin resistance and atherosclerosis.","volume":"56","author":"Zsuga","year":"2007","journal-title":"Metabolism."},{"key":"B75","doi-asserted-by":"publisher","first-page":"2842S","DOI":"10.1093\/jn\/134.10.2842S","article-title":"Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, explains the \u201cL-arginine paradox\u201d and acts as a novel cardiovascular risk factor.","author":"Boger","year":"2004","journal-title":"J Nutr."},{"key":"B76","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1177\/1358863X10364552","article-title":"Asymmetric dimethylarginine correlates with measures of disease severity, major adverse cardiovascular events and all-cause mortality in patients with peripheral arterial disease.","volume":"15","author":"Wilson","year":"2010","journal-title":"Vasc Med."},{"key":"B77","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.niox.2021.03.002","article-title":"Prognostic value of asymmetric dimethylarginine in patients with coronary artery disease: A meta-analysis.","volume":"110","author":"Ye","year":"2021","journal-title":"Nitric Oxide."},{"key":"B78","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1002\/ddr.21200","article-title":"Decrease of asymmetric dimethyl arginine after anti-TNF therapy in patients with rheumatoid arthritis.","author":"Spinelli","year":"2014","journal-title":"Drug Dev Res."},{"key":"B79","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/S1734-1140(13)71070-3","article-title":"Disparate effects of anti-TNF-alpha therapies on measures of disease activity and mediators of endothelial damage in ankylosing spondylitis.","volume":"65","author":"Korkosz","year":"2013","journal-title":"Pharmacol Rep."},{"key":"B80","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.1111\/j.1755-5922.2009.00119.x","article-title":"Effects of long-term disease-modifying antirheumatic drugs on endothelial function in patients with early rheumatoid arthritis.","volume":"28","author":"Turiel","year":"2010","journal-title":"Cardiovasc Ther."},{"key":"B81","first-page":"749","article-title":"Asymmetric dimethylarginine serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-alpha antagonist therapy.","volume":"31","author":"Genre","year":"2013","journal-title":"Clin Exp Rheumatol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.atherosclerosis.2014.12.030","article-title":"Plasma arginine\/ADMA ratio as a sensitive risk marker for atherosclerosis: Shimane CoHRE study.","volume":"239","author":"Notsu","year":"2015","journal-title":"Atherosclerosis."},{"key":"B83","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1134\/S0006297921020036","article-title":"The mechanisms of l-arginine metabolism disorder in endothelial cells.","volume":"86","author":"Mammedova","year":"2021","journal-title":"Biochemistry (Mosc)."},{"key":"B84","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.atherosclerosis.2012.08.033","article-title":"The L-arginine\/asymmetric dimethylarginine ratio is improved by anti-tumor necrosis factor-alpha therapy in inflammatory arthropathies. Associations with aortic stiffness.","volume":"225","author":"Angel","year":"2012","journal-title":"Atherosclerosis."},{"key":"B85","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1002\/art.1780400418","article-title":"Abnormal homocysteine metabolism in rheumatoid arthritis.","volume":"40","author":"Roubenoff","year":"1997","journal-title":"Arthritis Rheum."},{"key":"B86","first-page":"92","article-title":"Association between homocysteine levels and arterial stiffness in women with systemic sclerosis.","author":"Alvarez-Cienfuegos","year":"2020","journal-title":"Clin Exp Rheumatol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1111\/jch.12555","article-title":"Plasma homocysteine is a predictive factor for arterial stiffness: A community-based 4.8-year prospective study.","volume":"17","author":"Wang","year":"2015","journal-title":"J Clin Hypertens (Greenwich)."},{"key":"B88","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/jhh.2015.17","article-title":"Interactions between plasma homocysteine and arterial stiffness in chronic kidney disease in community-dwelling individuals: The Maine-Syracuse Study.","volume":"29","author":"Elias","year":"2015","journal-title":"J Hum Hypertens."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1093\/ajcn\/86.5.1438","article-title":"Plasma arginine and citrulline concentrations in critically ill children: strong relation with inflammation.","volume":"86","author":"van Waardenburg","year":"2007","journal-title":"Am J Clin Nutr."},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28793","article-title":"Citrulline as a biomarker of bacteraemia during induction treatment for childhood acute lymphoblastic leukaemia.","volume":"68","author":"De Pietri","year":"2020","journal-title":"Pediatr Blood Cancer."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.1011734\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T06:14:40Z","timestamp":1668060880000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.1011734\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,10]]},"references-count":90,"alternative-id":["10.3389\/fmed.2022.1011734"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.1011734","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,10]]},"article-number":"1011734"}}